Related Experiment Video

Updated: May 19, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Novel immune signals and atherosclerosis

Hiroshi Iwata1, Ryozo Nagai

  • 1Brigham and Women's Hospital, Department of Medicine, Cardiovascular Division, Center for Interdisciplinary Cardiovascular Sciences, 3 Blackfan Street, 17th Floor, Boston, MA 02115, USA. hiroiwata-circ@umin.ac.jp

Current Atherosclerosis Reports
|August 7, 2012
PubMed

Insights

Atherosclerosis, a chronic inflammatory process, involves immune signals and monocyte/macrophage biology. Understanding these mechanisms, including toll-like receptors (TLRs), is key to developing novel treatments for cardiovascular disease.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Molecular Biology

Background:

  • Atherosclerosis is the primary cause of coronary artery disease (CAD) and cerebrovascular disease, leading causes of mortality.
  • Cardiovascular disease risk is reduced by controlling risk factors, notably lowering low-density lipoprotein (LDL) cholesterol with statins.
  • Atherosclerosis is characterized as a chronic inflammatory condition initiated by risk factors, leading to endothelial dysfunction and inflammatory cell infiltration.

Purpose of the Study:

  • To review the molecular mechanisms of immune signaling in atherosclerosis development and progression.
  • To discuss the role of toll-like receptors (TLRs) in the pathogenesis of atherosclerosis.
  • To explore monocyte/macrophage biology, including polarization and heterogeneity, in atherosclerosis progression.

Main Methods:

  • Literature review summarizing current understanding of molecular mechanisms.
  • Focus on immune signals, specifically toll-like receptors (TLRs).
  • Analysis of monocyte/macrophage biology, including polarization and heterogeneity.

Main Results:

  • Toll-like receptors (TLRs) are identified as potent inducers of inflammation and play a significant role in atherosclerosis pathogenesis.
  • Monocyte and macrophage biology, encompassing polarization and heterogeneity, significantly contributes to atherosclerosis progression.
  • Current knowledge highlights the interplay between molecular mechanisms and immune cell behavior in atherosclerosis.

Conclusions:

  • Understanding the molecular mechanisms and immune cell orchestration is crucial for developing novel therapeutic strategies.
  • Targeting immune pathways and monocyte/macrophage behavior offers potential for preventing and treating atherosclerosis.
  • Further research into TLRs and macrophage dynamics can lead to innovative treatments for cardiovascular disorders.

More Related Videos

Flow Cytometry Analysis of Immune Cells Within Murine Aortas15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...